Tag: Down Syndrome
Lecanemab-Labeled Amyloid Plaques Identified in Down Syndrome
Extensive binding of lecanemab to brain blood vessels observed in Down syndrome postmortem brain tissue analysis
Differences ID’d in Tau Burden in Down Syndrome, Alzheimer Disease
Differences in spatial distribution, timing, magnitude of tau burden seen for two genetic forms of Alzheimer disease
Mortality Up 25-Fold for Congenital Heart Disease With Down Syndrome
Mortality rate twofold higher for patients with CHD with Down syndrome versus without
Walking Linked to Improved Cognitive Outcomes in Down Syndrome
Walking interactions can improve physical health and cognitive and executive function in adults with Down syndrome
Children With Down Syndrome Experience More Medical Imaging
More medical imaging, including CT, fluoroscopy, angiography, nuclear medicine, reported for those with Down syndrome, especially in those younger than 1 year
PET Changes Similar for Alzheimer Disease, Down Syndrome
No difference seen in global PET amyloid burden between asymptomatic with Down syndrome, asymptomatic mutation carriers
Incidence of Diabetes Increased for Youth With Down Syndrome
Incidence rates of type 1 and type 2 diabetes higher in individuals with Down syndrome
Upper Airway Stimulation Effective in Teens With Down Syndrome, OSA
73.2 percent of patients had AHI of less than 10 events/hour at 12 months; improvement also seen in quality of life
Health Supervision Discussed for Children With Down Syndrome
Guidance provided for counseling of pregnant women with prenatal diagnosis, care of the child from infancy through adolescence
Children With Down Syndrome at Higher Risk for Leukemia
Risk particularly high for acute myeloid leukemia before age 5 years
